Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck
Merck
Merck: Buyback Plan Not As Impressive As It Appears
Seeking Alpha
Sun, 03/29/15 - 11:38 am
Merck
stock buyback
11 promising drugs poised to be the next billion-dollar blockbusters
Yahoo/Business Insider
Sat, 03/28/15 - 10:26 am
Opdivo
Praluent
LCZ696
lumacaftor
Viekira Pak
evolocumab
Gardasil 9
brexpiprazole
Toujeo
Cosentyx
Bristol-Myers Squibb
Regeneron
Sanofi
Novartis
Pfizer
AbbVie
Amge
Astellas
Merck
Otsuka
Lundbeck
Vertex Pharmaceuticals
Two Experimental Ebola Vaccines Appear to Be Safe in Trial
WSJ Online
Fri, 03/27/15 - 08:32 am
vaccines
ebola virus
GSK
Merck
NewLink Genetics
Guinea starts testing Merck vaccine in Ebola hotspots
Yahoo/Reuters
Thu, 03/26/15 - 09:34 am
Merck
vaccines
ebola virus
WHO
Psoriasis data wars heat up at AAD with Novartis, Boehringer studies
Fierce Pharma Marketing
Thu, 03/26/15 - 07:38 am
Novartis
psoriasis
Boehringer Ingelheim
Pfizer
Xeljanz
Cosentyx
JNJ
Stelara
BI-655066
Amgen
AstraZeneca
Merck
Eli Lilly
Merck's stock gains after new $10 billion stock repurchase program announced
Marketwatch
Wed, 03/25/15 - 08:47 am
Merck
stock buyback
Merck says melanoma drug meets goal; study halted
Yahoo/Reuters
Tue, 03/24/15 - 03:11 pm
Merck
Keytruda
clinical trials
PD-1 inhibitors
Why 2015 is the year of the biopharma blockbuster—with charts
BioPharma Dive
Tue, 03/24/15 - 10:29 am
biotech
Opdivo
Praluent
LCZ696
Ibrance
Viekira Pak
evolocumab
Gardasil 9
Bristol-Myers Squibb
Regeneron
Sanofi
Novartis
Pfizer
Vertex Pharmaceuticals
Merck
Amgen
AbbVie
Astellas
4 Biotech Reports This Month That Could Move Stocks
Investors.com
Thu, 03/19/15 - 08:15 am
Biogen Idec
BIIB037
Genfit
NASH
GFT-505
Vertex Pharmaceuticals
VX-661
Merck
grazoprevir
Top 15 pharma companies by 2014 revenue
Fierce Pharma
Wed, 03/18/15 - 11:04 am
JNJ
Novartis
Roche
Pfizer
Sanofi
Merck
GSK
AstraZeneca
Bayer
Gilead Sciences: How Big a Threat is Merck?
Barron's
Tue, 03/17/15 - 07:17 pm
Merck
Gilead Sciences
hepatitis C
Merck Surgery Drug Sugammadex To Be Denied FDA Approval
Bidness Etc.
Sat, 03/14/15 - 02:48 pm
Merck
sugammadex
Merck cancer drug is first approved under UK early access scheme
Yahoo/Reuters
Wed, 03/11/15 - 10:43 am
Merck
Keytruda
UK
melanoma
Merck execs tout early yield from sleep drug Belsomra's launch
Fierce Pharma Marketing
Wed, 03/11/15 - 10:13 am
Merck
Belsomra
drug launches
insomnia
Layoffs at Cubist come amid a steady flow of senior execs out of Merck
Bizjournals.com
Sun, 03/8/15 - 10:10 am
Merck
Cubist Pharma
layoffs
Expect More M&A Activity In Red-Hot Biotech Group
Investors.com
Fri, 03/6/15 - 03:09 pm
biotech
M&A
AbbVie
Pharmacyclics
Isis Pharmaceuticals
JNJ
Merck
NewLink Genetics
Roche
Merck dumps 120 Cubist researchers after its $9.5B merger
Fierce Biotech
Thu, 03/5/15 - 05:51 pm
Merck
Cubist Pharma
layoffs
R&D
Eisai and Merck make cancer research pact
Medical Marketing and Media
Thu, 03/5/15 - 05:38 pm
Eisai
Merck
R&D
Merck-NewLink Ebola vaccine Phase III trial to start March 7
Yahoo/Reuters
Thu, 03/5/15 - 09:51 am
Merck
NewLink Genetics
vaccines
ebola virus
Merck touts a bright future in biosimilars with a stable of would-be blockbusters
Fierce Biotech
Wed, 03/4/15 - 09:51 am
Merck
biosimilars
AbbVie
Humira
JNJ
Remicade
Amgen
Enbrel
Samsung Bioepis
Biogen Idec
Pages
« first
‹ previous
…
95
96
97
98
99
100
101
102
103
…
next ›
last »